Other OTC Pharmaceuticals (Pharmacies) - Western Asia

  • Western Asia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$0.95bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.83%, resulting in a market volume of US$0.99bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.26 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Western Asia is experiencing significant growth and development.

Customer preferences:
Customers in Western Asia have shown a strong preference for over-the-counter (OTC) pharmaceuticals purchased from pharmacies. This preference can be attributed to several factors. Firstly, customers in this region value convenience and accessibility when it comes to healthcare products. Pharmacies offer a wide range of OTC medications that can be easily purchased without a prescription. Secondly, customers in Western Asia tend to trust the expertise and advice of pharmacists, who can provide guidance on the appropriate OTC medications for various health conditions. Finally, customers in this region often prefer OTC medications due to the lower cost compared to prescription drugs.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Western Asia is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of their health and are seeking alternative treatments that are perceived to be more natural and less invasive. This trend is driven by a growing awareness of the potential side effects of synthetic drugs and a desire for more holistic approaches to healthcare. As a result, pharmacies in Western Asia are expanding their offerings to include a wider range of natural and herbal OTC products. Another trend in the market is the rising popularity of online pharmacies. Customers in Western Asia are increasingly turning to online platforms to purchase OTC medications. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wider range of products compared to physical pharmacies. Online pharmacies also often offer competitive prices and discounts, which further attracts customers. As a result, traditional brick-and-mortar pharmacies are facing increased competition and are adapting their business models to include online sales channels.

Local special circumstances:
One of the unique aspects of the Other OTC Pharmaceuticals (Pharmacies) market in Western Asia is the cultural and religious factors that influence customer preferences. For example, in some countries in this region, there may be restrictions on the sale of certain medications or ingredients due to religious beliefs. This can impact the availability and variety of OTC products in pharmacies. Additionally, cultural beliefs and practices may influence the types of remedies and treatments that customers seek out. Pharmacies in Western Asia need to be aware of these local special circumstances and tailor their offerings accordingly.

Underlying macroeconomic factors:
Several macroeconomic factors contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Western Asia. Firstly, the region has experienced strong economic growth in recent years, leading to an increase in disposable income and healthcare spending. This has resulted in higher demand for OTC medications as customers have more purchasing power. Secondly, the growing population and urbanization in Western Asia have also contributed to the expansion of the market. As more people move to cities, the demand for healthcare products and services, including OTC medications, increases. Finally, government initiatives to improve healthcare access and affordability have also played a role in the development of the market. These factors combined create a favorable environment for the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Western Asia.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)